← Evidence map

ArticleCPT: pharmacometrics & systems pharmacology2026

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma.

John D Clements et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 42811422